Comparison Study of MDX-010 (CTLA-4) Alone and Combined With DTIC in the Treatment of Metastatic Melanoma

Piedmont Oncology Specialists, Charlotte

Indiana Oncology/ Hematology Consultants, Indianapolis

Joe Arrington Cancer. Research & Treatment Center, Lubbock

Huntsman Cancer Institute, Salt Lake City

Arizona Cancer Center, Tucson

USC/Norris Comprehensive Cancer Center, Los Angeles

Cancer Institute Medical Group, Santa Monica

Pacific Shores Medical Group, Long Beach

Northern California Melanoma Center, San Francisco